Skip to main content
Log in

Dual Oral Iron Chelation in Thalassemia: Need for Robust Evidence

  • Editorial Commentary
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Totadri S, Bansal D, Trehan A, et al. Hepatic and cardiac iron-load in children on long-term chelation with deferiprone for thalassemia major. Indian Pediatr. 2018;55:573–5.

    Article  Google Scholar 

  2. Totadri S, Bansal D, Bhatia P, Attri SV, Trehan A, Marwaha RK. The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: a prospective, single-center, open-label study: dual oral chelation with deferasirox and deferiprone. Pediatr Blood Cancer. 2015;62:1592–6.

    Article  CAS  Google Scholar 

  3. DivakarJose RR, Delhikumar CG, Ram KG. Efficacy and safety of combined oral chelation with deferiprone and deferasirox on iron overload in transfusion dependent children with thalassemia – a prospective observational study. Indian J Pediatr. 2020. https://doi.org/10.1007/s12098-020-03442-5.

  4. Gomber S, Jain P, Sharma S, Narang M. Comparative efficacy and safety of oral iron chelators and their novel combination in children with thalassemia. Indian Pediatr. 2016;53:207–10.

    Article  Google Scholar 

  5. Parakh N, Chandra J, Sharma S, Dhingra B, Jain R, Mahto D. Efficacy and safety of combined oral chelation with deferiprone and deferasirox in children with β-thalassemia major: an experience from North India. J Pediatr Hematol Oncol. 2017;39:209–13.

    Article  CAS  Google Scholar 

  6. Elalfy MS, Adly AM, Wali Y, Tony S, Samir A, Elhenawy YI. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta-thalassemia major patients. Eur J Haematol. 2015;95:411–20.

    Article  CAS  Google Scholar 

  7. Lal A, Bansal D. Thalassemia: common clinical queries in management. Indian J Pediatr. 2020;87:75–81.

    Article  Google Scholar 

  8. Trompeter S, Cohen A. Blood transfusion. In: Cappellini MD, Cohen A, Porter J, editors. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT), 3rd ed. Nicosia (CY): Thalassaemia International Federation; 2014. Chapter 2. Available at: https://www.ncbi.nlm.nih.gov/books/NBK269390/.

  9. Porter J, Viprakasit V. Iron overload and chelation. In: Cappellini MD, Cohen A, Porter J, editors. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT), 3rd ed. Nicosia (CY): Thalassaemia International Federation; 2014. Chapter 3. Available at: https://www.ncbi.nlm.nih.gov/books/NBK269373/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepak Bansal.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peyam, S., Bansal, D. Dual Oral Iron Chelation in Thalassemia: Need for Robust Evidence. Indian J Pediatr 88, 319–321 (2021). https://doi.org/10.1007/s12098-021-03698-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-021-03698-5

Navigation